Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients

Clinical Lung Cancer

Volumn 12, Issue 4, 2011, Pages 237-244

  Okamoto, Junichi ^a,b   Kratz, Johannes ^a   Hirata, Tomomi ^a,b   Mikami, Iwao ^a,b   Raz, Dan ^a   Segal, Mark ^c   Chen, Zhao ^a,d   Zhou, Hai Meng ^d   Pham, Patrick ^a   Li, Hui ^a   Beltran, Adam ^a   Ray, M Roshni ^a   Koizumi, Kiyoshi ^b   Shimizu, Kazuo ^b   Jablons, David ^a,e   He, Biao ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TSINGHUA UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Bronchioloalveolar carcinoma; Immunohistochemistry; Prognosis; RT PCR

Indexed keywords

TRANSCRIPTION FACTOR EMX2;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 79960381625     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.03.025     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108
2. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004; 126:347-51. (Pubitemid 39093415)
3. Little AG, Gay EG, Gaspar LE, et al. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer 2007; 57:253-60. (Pubitemid 47285417)
4. Sekine I, Nishiwaki Y, Yokose T, et al. Young lung cancer patients in Japan: different characteristics between the sexes. Ann Thorac Surg 1999; 67:1451-5. (Pubitemid 29320255)
5. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359: 1367-80.
6. Jemal A. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-49.
7. Guo L, Ma Y, Ward R, et al. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res 2006; 12:3344-54.
8. Coate LE, John T, Tsao MS, et al. Molecular predictive and prognostic markers in non-small-cell lung cancer. Lancet Oncol 2009; 10:1001-10
9. Kratz JR, Jablons DM. Genomic prognostic models in early-stage lung cancer. Clin Lung Cancer 2009; 10:151-7.
10. He B, Barg RN, You L, et al. Wnt signaling in stem cells and non-small-cell lung cancer. Clin Lung Cancer 2005; 7:54-60. (Pubitemid 41150474)
11. Mazieres J, He B, You L, et al. Wnt signaling in lung cancer. Cancer Lett 2005; 222:1-10. (Pubitemid 40544841)
12. Uematsu K, He B, YouL, et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22:7218-21. (Pubitemid 37378553)
13. Nguyen DX, Chiang AC, Zhang XH, et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009; 138:51-62
14. Dalton D, Chadwick R, McGinnis W. Expression and embryonic function of empty spiracles: a Drosophila homeo box gene with two patterning functions on the anterior-posterior axis of the embryo. Genes Dev 1989; 3:1940-56. (Pubitemid 20023219)
15. Galli R, Fiocco R, De Filippis L, et al. Emx2 regulates the proliferation of stem cells of the adult mammalian central nervous system. Development 2002; 129:1633-44. (Pubitemid 34874181)
16. Taylor HS, Fei X. Emx2 regulates mammalian reproduction by altering endometrial cell proliferation. Mol Endocrinol 2005; 19:2839-46. (Pubitemid 41577253)
17. Ligon KL, Echelard Y, Assimacopoulos S, et al. Loss of Emx2 function leads to ectopic expression of Wnt1 in the developing telencephalon and cortical dysplasia. Development 2003; 130:2275-87. (Pubitemid 36656721)
18. Noonan FC, Mutch DG, Ann Mallon M, et al. Characterization of the homeodo-main gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers. Genomics 2001; 76:37-44. (Pubitemid 32744622)
19. Lind GE, Skotheim RI, Fraga MF, et al. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol 2006; 210:441-9. (Pubitemid 44830604)
20. Okamoto J, Hirata T, Chen Z, et al. EMX2 is epigenetically silenced and suppresses growth in human lung cancer [published erratum appears in: Oncogene 2010; 29: 5976. Beltran, A (corrected to Yagui-Beltran, A)]. Oncogene 2010; 29:5969-75.
21. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-7. (Pubitemid 27260107)
22. Raz DJ, Ray MR, Kim JY, et al. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Clin Cancer Res 2008; 14:5565-70.
23. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8. (Pubitemid 351818697)
24. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines. Technical Report, Mayo Foundation (Rochester, MN) 1997.
25. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-87. (Pubitemid 26072233)
26. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8:816-24.
27. Bianchi F, Nuciforo P, Vecchi M, et al. Survival prediction of stage I lung adeno-carcinomas by expression of 10 genes. J Clin Invest 2007; 117:3436-44. (Pubitemid 350096999)
28. Potti A. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006; 355:570-80. (Pubitemid 44200650)
29. Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 2006; 66:7466-72. (Pubitemid 44289200)
30. Reed CE, Graham A, Hoda RS, et al. A simple two-gene prognostic model for adenocarcinoma of the lung. J Thorac Cardiovasc Surg 2008; 135:627-34.
31. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20.
32. Raz DJ, He B, Rosell R, et al. Bronchioloalveolar carcinoma: a review. Clin Lung Cancer 2006; 7:313-22. (Pubitemid 43950978)
33. Saad RS, Liu Y, Han H, et al. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adeno-carcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol 2004; 17:1235-42. (Pubitemid 39328130)
34. Saad RS, Liu YL, Han H, et al. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchi-oloalveolar carcinoma of the lung. Hum Pathol 2004; 35:3-7. (Pubitemid 38139310)
35. Gao P, Yang X, Xue YW, et al. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Cancer 2009; 115:3222-32.
36. Sarkaria IS, Pham D, Ghossein RA, et al. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Ann Thorac Surg 2004; 78:1734-41. (Pubitemid 39423544)
37. von Ahlfen S, Missel A, Bendrat K, et al. Determinants of RNA quality from FFPE samples. PLoS One 2007; 2:e1261
38. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009; 136:260-71.
39. Paik S. Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. Oncologist 2007; 12:631-5. (Pubitemid 47036199)
40. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States 2007 [published erratum appears in: MMWR Morb Mortal Wkly Rep 2008; 57:1281]. MMWR Morb Mortal Wkly Rep 2008; 57: 1221-6.